LCB 03-0110, a Novel Pan-Discoidin Domain Receptor/c-Src Family Tyrosine Kinase Inhibitor, Suppresses Scar Formation by Inhibiting Fibroblast and Macrophage Activation-Reference-Cited by-同舟云学术

LCB 03-0110, a Novel Pan-Discoidin Domain Receptor/c-Src Family Tyrosine Kinase Inhibitor, Suppresses Scar Formation by Inhibiting Fibroblast and Macrophage Activation

Published:2011-11-29 Issue:3 Volume:340 Page:510-519
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Sun Xiaoyan,Phan Trong Nhat,Jung Seung Hee,Kim Sun Young,Cho Jong Un,Lee Hyangsook,Woo Sung Ho,Park Tae Kyo,Yang Beom-Seok

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference48 articles.

1. Discoidin Domain Receptor 1–deficient Mice Are Resistant to Bleomycin-induced Lung Fibrosis

2. Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors

3. Beta 2 integrin-dependent protein tyrosine phosphorylation and activation of the FGR protein tyrosine kinase in human neutrophils.

4. The Src, Syk, and Tec family kinases: Distinct types of molecular switches

5. The immunopathogenesis of sepsis

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research progress of DDR1 inhibitors in the treatment of multiple human diseases;European Journal of Medicinal Chemistry;2024-03

2. Focusing on discoidin domain receptors in premalignant and malignant liver diseases;Frontiers in Oncology;2023-03-15

3. Discoidin domain receptor 1 may be involved in biological barrier homeostasis;Journal of Clinical Pharmacy and Therapeutics;2022-06-04

4. Discoidin Domain Receptor 2: A New Target in Cancer;Oncology Research and Treatment;2022

5. Research Progress of Discoid Domain Receptor 1 (DDR1) Inhibitors;Chinese Journal of Organic Chemistry;2022